Grand Junction, CO1 Active Studies

Ankylosing Spondylitis Clinical Trials in Grand Junction, CO

Find 1 actively recruiting ankylosing spondylitis clinical trials in Grand Junction, CO. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
1,000
Enrolling

Recruiting Ankylosing Spondylitis Studies in Grand Junction

About Ankylosing Spondylitis Clinical Trials in Grand Junction

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 1 ankylosing spondylitis clinical trials recruiting participants in Grand Junction, CO. These studies are seeking a combined 1,000 participants. Research is being sponsored by Merck Sharp & Dohme LLC. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Grand Junction — FAQ

Are there ankylosing spondylitis clinical trials in Grand Junction?

Yes, there are 1 ankylosing spondylitis clinical trials currently recruiting in Grand Junction, CO. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Grand Junction?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Grand Junction research site will contact you about next steps.

Are clinical trials in Grand Junction free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Grand Junction studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 1 active trials in Grand Junction are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated July 22, 2026 from ClinicalTrials.gov